Saw palmetto berry in the treatment of benign prostatic hyperplasia

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Phytotherapeutic agents are widely used for treating the symptoms of benign prostatic hyperplasia (BPH). Saw palmetto berry (SPB) is the most widely studied of these agents. It's mechanism of action is poorly understood. It does not have 5-alpha-reductase activity. The active ingredient in this extract is also unknown. There is much controversy concerning the efficacy of SPB. The double-blind trials, although usually favorable, do not show usual placebo response as seen in other BPH studies. Because of the variability of the natural history of BPH, the uncontrolled studies of these agents contribute little to determine efficacy. Further well-design placebo-controlled trials are necessary to establish the safety and efficacy of phytotherapy in the treatment of BPH.

Original languageEnglish (US)
Pages (from-to)53-66
Number of pages14
JournalClinical Research and Regulatory Affairs
Volume14
Issue number1
StatePublished - 1997
Externally publishedYes

Fingerprint

Prostatic Hyperplasia
Fruit
Cholestenone 5 alpha-Reductase
Placebos
Phytotherapy
Therapeutics
Safety

ASJC Scopus subject areas

  • Molecular Medicine
  • Pharmaceutical Science

Cite this

Saw palmetto berry in the treatment of benign prostatic hyperplasia. / Lowe, Franklin C.

In: Clinical Research and Regulatory Affairs, Vol. 14, No. 1, 1997, p. 53-66.

Research output: Contribution to journalArticle

@article{7e56e300d1e84e1fbdda3cc581a0fac5,
title = "Saw palmetto berry in the treatment of benign prostatic hyperplasia",
abstract = "Phytotherapeutic agents are widely used for treating the symptoms of benign prostatic hyperplasia (BPH). Saw palmetto berry (SPB) is the most widely studied of these agents. It's mechanism of action is poorly understood. It does not have 5-alpha-reductase activity. The active ingredient in this extract is also unknown. There is much controversy concerning the efficacy of SPB. The double-blind trials, although usually favorable, do not show usual placebo response as seen in other BPH studies. Because of the variability of the natural history of BPH, the uncontrolled studies of these agents contribute little to determine efficacy. Further well-design placebo-controlled trials are necessary to establish the safety and efficacy of phytotherapy in the treatment of BPH.",
author = "Lowe, {Franklin C.}",
year = "1997",
language = "English (US)",
volume = "14",
pages = "53--66",
journal = "Clinical Research Practices and Drug Regulatory Affairs",
issn = "1060-1333",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Saw palmetto berry in the treatment of benign prostatic hyperplasia

AU - Lowe, Franklin C.

PY - 1997

Y1 - 1997

N2 - Phytotherapeutic agents are widely used for treating the symptoms of benign prostatic hyperplasia (BPH). Saw palmetto berry (SPB) is the most widely studied of these agents. It's mechanism of action is poorly understood. It does not have 5-alpha-reductase activity. The active ingredient in this extract is also unknown. There is much controversy concerning the efficacy of SPB. The double-blind trials, although usually favorable, do not show usual placebo response as seen in other BPH studies. Because of the variability of the natural history of BPH, the uncontrolled studies of these agents contribute little to determine efficacy. Further well-design placebo-controlled trials are necessary to establish the safety and efficacy of phytotherapy in the treatment of BPH.

AB - Phytotherapeutic agents are widely used for treating the symptoms of benign prostatic hyperplasia (BPH). Saw palmetto berry (SPB) is the most widely studied of these agents. It's mechanism of action is poorly understood. It does not have 5-alpha-reductase activity. The active ingredient in this extract is also unknown. There is much controversy concerning the efficacy of SPB. The double-blind trials, although usually favorable, do not show usual placebo response as seen in other BPH studies. Because of the variability of the natural history of BPH, the uncontrolled studies of these agents contribute little to determine efficacy. Further well-design placebo-controlled trials are necessary to establish the safety and efficacy of phytotherapy in the treatment of BPH.

UR - http://www.scopus.com/inward/record.url?scp=0030960246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030960246&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0030960246

VL - 14

SP - 53

EP - 66

JO - Clinical Research Practices and Drug Regulatory Affairs

JF - Clinical Research Practices and Drug Regulatory Affairs

SN - 1060-1333

IS - 1

ER -